Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  infection
Trial Type:  Supportive care
Results 1-25 of 27 for your search:
Start Over
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
Phase: Phase III
Type: Supportive care
Age: 6 months to 21 years
Trial IDs: ACCL0934, NCI-2011-02636, CDR0000695661, COG-ACCL0934, NCT01371656
Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients with Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Age: 3 months to 30 years
Trial IDs: ACCL0933, NCI-2011-02640, CDR0000695748, COG-ACCL0933, NCT01307579
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients following Donor Stem Cell Transplant
Phase: Phase III
Type: Supportive care
Age: 3 months to 20 years
Trial IDs: ACCL1131, NCI-2012-00102, CDR0000721415, COG-ACCL1131, NCT01503515
A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069/P06200)
Phase: Phase III
Type: Supportive care
Age: 13 and over
Trial IDs: P06200, NCI-2013-02285, 2011-003938-14, 5592-069, NCT01782131
Donor Multi-virus-Specific Cytotoxic T Lymphocytes in Treating Epstein-Barr Virus, Cytomegalovirus, Adenovirus, Human Herpes Virus 6, and BK Virus Infections in Patients Who Have Undergone Donor Stem Cell Transplant
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Age: Not specified
Trial IDs: H-29966, NCI-2012-02979, ARMS, H-29966 ARMS, NCT01570283
Calaspargase Pegol or Pegaspargase in Treating Younger Patients with Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 365 days to 18 years
Trial IDs: 11-001, NCI-2012-00825, NCT01574274
White Blood Cell Transfusion in Preventing Infection in Patients with Acute Myelogenous Leukemia or Undergoing Front-Line or First Salvage Induction Therapy
Phase: Phase II
Type: Supportive care
Age: Not specified
Trial IDs: 2012-1158, NCI-2013-02208, NCT01932710
Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia
Phase: Phase II
Type: Supportive care
Age: 55 and over
Trial IDs: CLT008-03, NCI-2014-02461, NCT02282215
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients with Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Phase: Phase II
Type: Supportive care
Age: 18 to 75
Trial IDs: 13494, NCI-2015-00283, 118207, 118814, 119250, NCT02396134
Randomized Clinical Trial of Skin Closure with Staples versus Suture in Reducing Complications after Surgery in Patients with BMI of 30 or Greater
Phase: Phase II
Type: Supportive care
Age: 18 to 85
Trial IDs: 201304058, NCI-2013-01279, NCT01977612
Medical Home Care or Standard Hospital Care in Reducing Graft-versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: Pro00051024, NCI-2014-01942, NCT02218151
Cytotoxic T Lymphocytes in Treating Patients with BK Virus after Undergoing Stem Cell Transplant
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: 2014-0279, NCI-2015-01264, NCT02479698
Donor Lymphocyte Infusion in Treating Patients Previously Treated with Donor Stem Cell Transplant
Phase: Phase I
Type: Supportive care
Age: 18 and over
Trial IDs: Pro00003975, NCI-2013-00567, NCT01627275
Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097)
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Age: 2 to 17
Trial IDs: 5592-097, NCI-2015-01381, 2014-002807-10, MK-5592-097, NCT02452034
Voriconazole in Preventing or Treating Fungal Infections in Younger Patients Undergoing Stem Cell Transplant
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Age: 21 and under
Trial IDs: 2013LS126, NCI-2015-00535, CPRC #2013LS126, MT2013-37R, NCT02227797
Neutropenic Diet in Preventing Infections in Younger Patients Receiving Chemotherapy
Phase: No phase specified
Type: Supportive care
Age: 1 to 21
Trial IDs: 06-08-367, NCI-2014-01519, NCI-2014-01460, NCT00726934
Posaconazole or Micafungin Sodium in Treating Invasive Fungal Infections in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: 10-038, NCI-2010-02030, NCT01200355
Negative Pressure Therapy in Preventing Infection After Surgery in Patients With Colon, Rectal, Pancreatic, or Peritoneal Surface Cancer
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: CCCWFU 99212, NCI-2012-00624, NCT01656044
Donor Stem Cell Transplant in Treating Patients with High Risk Acute Myeloid Leukemia
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: Not specified
Trial IDs: 9L-11-8, NCI-2013-00447, HS-12-00080, NCT01801046
Standardized Nutritional Drink Before and After Surgery in Reducing Complications in Patients With Pancreatic Cancer
Phase: No phase specified
Type: Supportive care
Age: Over 18
Trial IDs: Pro00047214, NCI-2014-00036, NCT01947166
Cyclophosphamide in Preventing GVHD in Patients with Abnormal Kidney Function Undergoing Donor Stem Cell Transplant
Phase: No phase specified
Type: Natural history/Epidemiology, Supportive care
Age: 18 and over
Trial IDs: 14-273, NCI-2015-00266, NCT02360111
Start Over